CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (DEFICIT) - USD ($) $ in Thousands	Total	Common Class A	Common Class B	Common Stock Common Class A	Common Stock Common Class B	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2022				4,705,328	134,839
Beginning balance at Dec. 31, 2022	$ 520,619			$ 47	$ 1	$ 1,678,247	$ (1,160,618)	$ 2,942
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(35,901)						(35,901)
Compensation expense related to granting of stock awards (in shares)				195,724
Compensation expense related to granting of stock awards	1,949			$ 2		1,947
Purchase of vested employee restricted stock units (in shares)				(27,072)
Purchase of vested employee restricted stock units	(127)					(127)
Payment of dividends on common stock	(60)					(60)
Dividend equivalents, net of forfeitures	22						22
Net unrealized gain (loss) on derivatives	(840)							(840)
Ending balance (in shares) at Mar. 31, 2023				4,873,980	134,839
Ending balance at Mar. 31, 2023	485,662			$ 49	$ 1	1,680,007	(1,196,497)	2,102
Beginning balance (in shares) at Dec. 31, 2023		4,867,170	134,839	4,867,170	134,839
Beginning balance at Dec. 31, 2023	(614,753)			$ 49	$ 1	1,682,467	(2,297,270)	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(1,852)						(1,852)
Compensation expense related to granting of stock awards	304					304
Purchase of vested employee restricted stock units (in shares)				(7,411)
Purchase of vested employee restricted stock units	0
Net unrealized gain (loss) on derivatives	0
Ending balance (in shares) at Mar. 31, 2024		4,859,759	134,839	4,859,759	134,839
Ending balance at Mar. 31, 2024	$ (616,301)			$ 49	$ 1	$ 1,682,771	$ (2,299,122)	$ 0